Protalix Biotherapeutics Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$17,851	$15,658	$10,113	$18,218
Gross Profit	9,527	9,788	1,933	14,332
EBITDA	2,791	1,804	-3,380	7,656
EBIT	2,419	1,444	-3,726	7,322
Net Income	2,355	164	-3,619	6,494
Net Change In Cash	17,851	15,658	10,113	18,218
Free Cash Flow	-4,230	-5,664	-5,364	3,566
Cash	13,647	17,895	19,458	19,760
Basic Shares	80,814	81,271	76,612	81,057

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$53,399	$65,494	$47,638	$38,350
Gross Profit	29,080	42,512	28,046	22,001
EBITDA	6,520	12,937	-10,782	-18,943
EBIT	5,216	11,746	-11,868	-20,061
Net Income	2,932	8,312	-14,927	-27,582
Net Change In Cash	53,399	65,494	47,638	38,350
Free Cash Flow	7,392	-2,467	-25,628	-11,744
Cash	19,760	23,634	17,111	38,985
Basic Shares	81,057	82,424	48,472	44,140